The EC FP7 funded portion of the HELICOVAXOR® consortium is now complete and the final report has been submitted. A number of the members of the consortium continue to work together to further research oral adjuvanted vaccines. The critical needs for successful oral vaccine product development are to 1) find a bro...

Read More »


Throughout the course of the HELICOVAXOR® project, members of the consortium have continued to raise awareness of the potential for an oral, adjuvanted Helicobacter pylori vaccine through presentations and publications at international conferences and in scientific journals.  A list of publications is provided below:...

Read More »


In March 2015, the final report on the HELICOVAXOR® project was submitted to European Commission. While the work planned under the grant has been completed, the very promising results were not sufficient to justify moving to human clinical testing. A number of the consortium members continue to work together to ...

Read More »


In February 2015, members of the HELICOVAXOR® consortium met at Sigmoid Pharma's offices in Dublin to review the results of the project and to consider the preclinical, clinical, regulatory and commercial strategy for the further advancement of the HELICOVAXOR® oral vaccine against Helicobacter pylori infection....

Read More »


The initial activities of the consortium working on HELICOVAXOR® project funded under the European Community’s Seventh Framework Programme grant agreement number 315640 are mostly complete.  The consortium members are reviewing the data and planning next steps....

Read More »


July 19, 2013.  All participants involved in the HELICOVAXOR consortium participated in a review of progress to date and planning for future activities and deliverables.  The formal Mid-Term Review with the European Commission Research Executive Agency (REA) will take place in Brussels on September 30th, 2013.  Al...

Read More »


The XXVIth International Workshop on Helicobacter and related bacteria in chronic digestive inflammation organised by the European Helicobacter Study Group will take place in Madrid, Spain, September 12-14, 2013. Details are available on the website http://www.helicobacter.org/2013/invitation.htm  ...

Read More »


Representatives from the three SMEs leading the HELICOVAXOR™ Consortium met on November 14, 2012 in Zurich to review and agree the plan to develop an overall Helicobacter pylori vaccine.   All members of the consortium met on December 10, 2012 for the formal kick off meeting....

Read More »